Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?

Diabetes Care · 2017 · PMC5481984 · PMID 28637886

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significanceP = 0.09so close (0.05 < p ≤ 0.1)

The primary end point (3-point MACE plus coronary and leg revascularization) did not reach statistical significance (HR = 0.90, P = 0.09); however, it is now well recognized that peripheral vascular disease is refractory to antihypertensive, lipid-lowering, and glucose-lowering therapy ( 24 , 25 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.